Dark Streaming/Mobile Old Site Home Products Help Contact Us Your Account System Status
Sign-up for a FREE 30-day Stockwatch subscription and SEE NO ADS
06:02:28 EDT Wed 09 Jul 2025
Enter Symbol
or Name
USA
CA



C:PREV - PreveCeutical Medical Inc. - https://www.preveceutical.com
Sym-XBid - AskLastChg%ChVol$Vol#TrOpen-Hi-LoYear Hi-LoLast TrNewsDelay
PREV - C  222.80.03·0.035272.00.035163.05100.035  0.035  0.030.045  0.015Jul 08Jun 3015 min RT 2¢
CSE - C222.80.03·0.035272.00.035153.0570.035  0.035  0.030.045  0.015Jul 0815 min
Omega - O 0.03-0.005-14.31.010.03  0.03  0.03Jul 0815 min
CX2 - H 0.0359.0020.03  0.035  0.03Jul 0815 min

Recent Trades - All 10 today
Time ETExPriceChangeVolumeBuyerSellerMarkers
        
        
        
        
        
        
        
        
        
        

Sign-up for a FREE 30-day Stockwatch subscription and SEE NO ADS

Recent Bulletins
Date ETSymbolPriceTypeHeadline
2025-06-30 18:02C:PREV0.03News ReleasePreveceutical appoints Tavares chief technology officer
2025-06-25 16:28C:PREV0.035News ReleasePreveceutical to hold AGM Aug. 15
2025-06-11 19:01C:PREV0.035News ReleasePreveceutical arranges $750,000 private placement
2025-06-02 16:45C:PREV0.04News ReleasePreveceutical appoints Sampath as corporate adviser
2025-05-30 16:50C:PREV0.045SEDAR Interim Financial StatementsSEDAR Interim Financial Statements
2025-05-30 16:50C:PREV0.045SEDAR Interim MD & ASEDAR Interim MD & A
2025-05-26 15:53C:PREV0.035News ReleasePreveceutical appoints Glover as corporate adviser
2025-05-22 19:35C:PREV0.035News ReleasePreveceutical closes $748,383 private placement
2025-05-14 07:01C:PREV0.035News ReleasePreveCeutical Medical Inc. Announces Launch of New Website for BioGene Therapeutics Inc., Expanding Its Digital Presence to Enhance Accessibility and Awareness of Innovative Therapies
2025-04-30 19:12C:PREV0.03SEDAR MD & ASEDAR MD & A
2025-04-30 18:59C:PREV0.03SEDAR Audited Annual Financial StatementsSEDAR Audited Annual Financial Statements
2025-04-28 20:45C:PREV0.03News ReleasePreveceutical Medical closes first tranche of financing
2025-04-15 04:12C:PREV0.03News ReleasePreveceutical further increases placement to $700,000
2025-04-02 19:47C:PREV0.025News ReleasePreveceutical increases private placement to $500,000
2025-03-10 19:21C:PREV0.02News ReleasePreveceutical Medical extends private placement
2025-02-06 16:06C:PREV0.03News ReleasePreveceutical to develop N2B Sol-Gel program
2025-02-04 17:33C:PREV0.025News ReleasePreveceutical appoints Jones to lead Sol-Gel projects
2025-01-24 17:42C:PREV0.025News ReleasePreveceutical Medical arranges $300,000 unit financing
2025-01-07 12:55C:PREV0.025News ReleaseBioGene Therapeutics to Participate in the 43rd JP Morgan Healthcare Conference
2024-12-18 19:05C:PREV0.02News ReleasePreveceutical changes auditor to Davidson & Company